Peering into the innards of the Exchange-Traded Funds (ETFs) in our coverage realm at ETF Channel, we have meticulously juxtaposed the trading value of each holding against the average analyst target price projected over 12 months. Through this intricate calculation, we’ve derived the weighted average implied analyst target price for the ETF at hand. Unveiling the intriguing tale of the First Trust Consumer Discretionary AlphaDEX Fund ETF, known by its symbol FXD, we’ve unearthed the tantalizing revelation that the ETF has an implied analyst target price of $67.33 per unit.
At its current market price hovering around $61.38 per unit, this implies a potential 9.70% ascension for this ETF according to the collective wisdom of the average analyst targets set for the underlying holdings. Notable among these holdings are lululemon athletica inc (LULU), Ulta Beauty Inc (ULTA), and PVH Corp (PVH) – all poised for a promising journey ahead. LULU, currently trading at $357.56 per share, has an average analyst target of $492.58 per share, representing a substantial 37.76% growth if realized. Similarly, ULTA stands to gain by 30.16% from its recent share price of $448.64 should it ascend to the average target price of $583.95 per share. Moving on, analysts are pegging PVH to hit a target price of $136.36 per share, a substantial 28.17% above its current price of $106.39. A visual representation of their stock performance over the past year is encapsulated in the chart below:

Provided below is a succinct tabulation of the current analyst target prices discussed above:
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
|---|---|---|---|---|
| First Trust Consumer Discretionary AlphaDEX Fund ETF | FXD | $61.38 | $67.33 | 9.70% |
| lululemon athletica inc | LULU | $357.56 | $492.58 | 37.76% |
| Ulta Beauty Inc | ULTA | $448.64 | $583.95 | 30.16% |
| PVH Corp | PVH | $106.39 | $136.36 | 28.17% |
Are these analyst targets rooted in reality, or are they overly sanguine about where these stocks might be a year from now? Do the analysts hold a strong rationale for their targets, or are they falling short on grasping the latest company and industry developments? A lofty price target juxtaposed with a stock’s trading value could epitomize hope for the future while also signaling an impending downgrade in target prices if they remain relics of the past. These are ponderings that beckon further exploration and scrutiny from investors.
Discover the 10 ETFs Showing the Most Potential for Growth According to Analyst Targets »
Further Reading:
• Delve into the Top Ten Hedge Funds Holding HSKA
• Explore the Year-to-Date Returns of LIQT
• Unravel the Split History of VLGEA
Opinions shared in this piece are those of the author and do not necessarily mirror those of Nasdaq, Inc.






